Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy

Oracle's position in the cloud and AI was cemented in F2025, positioning the company to accelerate its growth over the next two years.

U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave

U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave

China, emerging markets, and Europe have outperformed the U.S. in 2025, with China’s FXI ETF up 18%, EEM up 4%, and IEV up 13% YTD.

Joby Aviation: From Prototype to Profitability

Joby Aviation: From Prototype to Profitability

Joby Aviation's air taxi vision takes flight, solidifying market leadership through certification strength, funding and operational gains.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Marvell’s 40% Drop Presents a Compelling Buying Opportunity

AI-driven chip stock Marvell is down in the dumps to start 2025. Is now the time to get in, or wait for the dust in the market to settle?

These 3 Dividend Stocks Jumped 15% in a Month—More to Come?

Dividend stocks aren't just for long-term income generation. These three shares have jumped 15% in one month while also offering dividend payouts.

Tesla Stock Is Oversold - Is Now the Time to Be Brave?

Tesla is down 55% from its high, but analysts still see 150% upside. In addition, an RSI of 20 suggests extreme oversold conditions.

3 Stocks Institutions Are Quietly Dumping

Institutions have been selling out of discretionary consumer names lately, signaling a loss of confidence in the underlying economy and spending.

inkl

Read news from The Economist, FT, and more,
with one subscription

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.

5 ETFs Poised to Spring Ahead in the Second Quarter

5 ETFs Poised to Spring Ahead in the Second Quarter

Here are five thematic ETFs that appear to be ideal for the current market conditions; each fund is delivering strong performance with low fees

3 Stocks With Sky-High Buyback Yields Over the Last 12 Months

3 Stocks With Sky-High Buyback Yields Over the Last 12 Months

Check out these three stocks that have bought back shares big-time over the past 12 months, resulting in buyback yields of 10% or more.

Top 3 Utilities Stocks Powering Up as Recession Fears Rise

Top 3 Utilities Stocks Powering Up as Recession Fears Rise

Three utilities firms may stand out to investors seeking a refuge amid concerns about an impending recession, although each has a different profile.

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential

Uncover five promising stocks under $10, each poised for gains across diverse sectors for the second quarter of 2025.

Costco Price Plunge Equals Opportunity for Investors

Costco Price Plunge Equals Opportunity for Investors

Costco continues to take share from its competitors as it leads the industry in growth. Analysts are lifting their stock price targets, leading to new highs.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Stocks Investing $650 Billion in the U.S.—Should You Invest?

See which three large-cap stocks are planning to invest a total of over $650 billion in the United States over the next several years.

Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease.

3 Tech Stocks Defying Sector Weakness and Thriving in 2025

Check out these three tech stocks that are all up at least 15% this year. They are defying the disappointing performance of the tech sector so far in 2025.

Energy and Basic Materials Sectors Will Dominate in 2025

Put option buyers might have just bet the wrong way about the energy and basic materials sectors, where investors can profit.

Get all your
news in one place.

100's of premium titles.
One news app.

Silver Pushes Past Gold This Year, These Stocks Will Capitalize

Three companies focusing primarily on silver mining may appeal to investors looking to capitalize on the metal's strong performance in 2025.

These 3 Q1 Earnings Winners Will Go Higher

Despite a lackluster earnings season for many companies, these three firms stood out and exhibited signs of likely future growth as a bonus.

Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality

Archer Aviation's Midnight aircraft is showing great potential in the eVTOL market, supported by strong financial backing and key strategic partnerships.

3 Defensive Investments for a Market Under Pressure

Defensive investments like Gold, Consumer Staples, and Dividend ETFs offer stability, steady income, and diversification, helping investors amid uncertainty.

Meta Stock: The Potential and Pitfalls of Its Reality Labs Bet

Meta Platforms keeps doubling down on its Reality Labs. What is the company's strategy, and what potentially huge benefits could it offer the stock long-term?

If You Could Only Hold 3 Investments for Life, Consider These

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

3 Stocks to Consider With a Possible Recession on the Table

As recession indicators begin to flash, investors may turn to defensive plays for protection—these three stocks offer a compelling case for sturdiness.

1 … 232 233 234 235

People

193,868 stories

Stephane Bancel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Emerging Markets

Places

381,760 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play